Diagnosis & Screening
Not everyone with an elevated prostate-specific antigen (PSA) test needs a prostate biopsy. At NewYork-Presbyterian, we use advanced blood and urine tests to determine which PSA test results warrant further evaluation to decide if you need a biopsy. This approach optimizes our ability to detect aggressive cancers, avoid unnecessary procedures, and minimize the risk of detecting tumors that may not affect a man’s health. Our teams take a precision management approach, using specialized magnetic resonance imaging (MRI) scans to guide biopsies and select the best treatment.
For men with an elevated risk for prostate cancer due to a personal or family medical history, we offer genetic counseling and testing. Our teams promote shared decision-making between doctors and patients regarding screening tests and biopsy decisions.
To Treat or Not to Treat?
One of the biggest challenges in prostate cancer care is distinguishing slow-growing tumors that can be watched from more aggressive cancers that require treatment. Our prostate cancer specialists and scientists are world leaders in combining imaging techniques with molecular markers to help make this distinction and improve diagnosis. We unite experts from different disciplines — including surgery, radiation oncology, and medical oncology — to educate you about your options.
Robotic Prostate Cancer Surgery
If you need prostate cancer surgery, you may be able to have it robotically, which gives the surgeon an enhanced view of the surgical field and allows for a more precise minimally-invasive operation. Our urologic surgeons are highly experienced in the latest procedures, including nerve-sparing prostatectomy — designed to preserve erectile and urinary function.
Precision Medicine for Early-Stage Prostate Cancer
Men with early-stage prostate cancer confined to the gland may receive localized treatment that does not require surgery — sparing nearby healthy tissues as much as possible and reducing your risk of side effects — such as:
- Radiation therapy, including hypofractionated radiation therapy (higher doses of radiation given over a shorter time period than standard radiation therapy) and MRI-guided treatment that shows your tumor’s position in real-time.
- Brachytherapy, tiny radioactive seeds implanted directly into the prostate. With computer-guided technology, we can plan and perform seeding during one procedure.
- High-intensity focused ultrasound (HIFU), the application of MRI-guided high-energy sound waves to heat and destroy prostate cancer cells.
- Cryosurgery, the insertion of needles into the prostate to freeze and destroy prostate cancer cells, including "salvage" cryotherapy to treat prostate cancers that have continued to grow after radiation therapy.
Medical Therapies for Advanced Cancer
Some men with late-stage prostate cancer need hormonal therapy, chemotherapy, immunotherapy, or targeted therapies. Our prostate care teams match patients with the most effective medications. You can receive intravenous treatments in our modern infusion centers staffed with a team of specialists who monitor your treatment and ensure your comfort throughout the process.
Clinical Trials of Promising Treatments
Our investigators are continually studying the development and progression of prostate cancer in order to conduct clinical trials of novel therapies, including groundbreaking approaches like molecular imaging to visualize and treat prostate cancer that has metastasized. Your care team will let you know if you are eligible for a clinical trial.
Call for an Appointment
NewYork-Presbyterian/Columbia University Irving Medical Center
Herbert Irving Comprehensive Cancer Center
Please call to refer a patient or schedule an appointment
NewYork-Presbyterian/Weill Cornell Medical Center
Department of Urology
Weill Cornell Medicine Meyer Cancer Center in Partnership with NewYork-Presbyterian